This startup develops an AI-powered device for automated inflation during angioplasty procedures. The device precisely controls inflation speed and duration, offering programmable and automatically regulated operation to provide reproducible results for safer vascular treatments.
Funding
Funding not disclosed
Founders
Product
Problem
Balloon angioplasty, a common procedure with millions performed annually, faces a significant failure rate, with up to 30% of cases requiring further interventions. The success of angioplasty is often dependent on the variability introduced by manual operation, leading to inconsistent results.
Solution
Valux Medical's Intara is an AI-powered device designed to automate and enhance balloon angioplasty procedures. Connecting to a balloon catheter, Intara precisely controls the inflation speed and duration during the procedure. The device's programmable and automatically regulated operation aims to eliminate human variability, providing reproducible and reviewable results. By responding to disruptions caused by dilation, Intara seeks to improve outcomes and reduce complications for patients undergoing angioplasty.
Target Audience
The primary target audience includes vascular surgeons and interventional cardiologists seeking to improve the precision and consistency of angioplasty procedures.
Features
- AI-powered system for automated control of balloon inflation during angioplasty
- Programmable parameters for customized treatment protocols
- Real-time adjustment of inflation speed and duration in response to vessel conditions
- Reproducible and reviewable procedural data for quality control
- Potential for reduced complications and improved long-term outcomes